Lung Cancer Translational Research Grants

Apply

Research priorities

In Canada, lung cancer remains the leading cause of cancer-related deaths, yet it remains one of the most underfunded in terms of research. To address this major issue, the Cancer Research Society is investing $2 million in research on this disease.

This competition will fund up to 4 translational research projects that will contribute to:

improve early detection of lung cancer
develop more effective treatments
understand mechanisms of resistance to current treatments.

Program information

Eligibility

The principal investigator and co-applicants must hold a research position at a Canadian institution and be able to hold research funds at their institution.

Budget

Each grant is limited to a maximum of $500,000 over a 3-year period.

Application process

A letter of intent is required for all applications. Selected applicants will be invited to submit a full application, which will be evaluated by an international panel of experts.

Together to outsmart lung cancer

This major investment was made possible by the exceptional generosity of donors, including the Fondation Famille Gosselin, The Molson Foundation, and the George Papadopoulos Memorial Fund. It reflects a deep commitment to research and innovation, with the hope of offering a brighter future to those affected.